Abbott Laboratories is recalling 8,424 units of the Alinity ci-series System Control Module due to multiple software defects in versions 3.4.0 and lower. These defects include errors in reagent loading, laboratory reporting, and assay information processing, which can lead to incorrect diagnostic results for various medical tests. The issue also involves physical defects such as labels not sticking to reagent bottles and hardware modules failing to expire after their warranty period.
The software and hardware issues can cause the system to produce erroneous patient test results for multiple analytes, which could lead to incorrect medical diagnoses or delayed treatments. No specific patient injuries have been reported in the data, but the potential for diagnostic error across thousands of systems represents a significant clinical risk.
Software update and manufacturer guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.